Hassan Fred - May 14, 2021 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
Director
Signature
/s/ Timothy K. Andrews, as attorney-in-fact for Fred Hassan
Stock symbol
RXDX
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/17/2021, 07:24 PM
Next filing
Aug 26, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +40K $0.00 40K May 14, 2021 Common Stock 40K $16.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on May 14, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.